BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37804440)

  • 1. Primary intracranial lymphomas-incidence and survival: a population-based study.
    Jiang Y; Zheng X; Lu T; Gao P; Wang Y
    Neurosurg Rev; 2023 Oct; 46(1):265. PubMed ID: 37804440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
    Xiao M; Lin J; Xiao T; Lin Y; Ye Y
    Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
    Lei Y; Huang Q; Li X; Zheng X; Liu M
    Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
    Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
    Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis.
    He LF; Zhang JD; Chen XX; Wei RL
    BMC Ophthalmol; 2022 Dec; 22(1):486. PubMed ID: 36514001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 8. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Urinary Tract Lymphoma: Rare but Aggressive.
    Lontos K; Tsagianni A; Msaouel P; Appleman LJ; Nasioudis D
    Anticancer Res; 2017 Dec; 37(12):6989-6995. PubMed ID: 29187485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of local treatment in primary breast B-cell non-Hodgkin's lymphoma: a propensity score matching-based analysis from SEER database.
    Zhang M; Liu N; Wang BY; Zhang J; Zhao A; Yang J; Yang J
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):22-31. PubMed ID: 35049015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cardiac lymphoma.
    Yin K; Brydges H; Lawrence KW; Wei Y; Karlson KJ; McAneny DB; Edwards NM; Reardon MJ; Dobrilovic N
    J Thorac Cardiovasc Surg; 2022 Aug; 164(2):573-580.e1. PubMed ID: 33158567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
    Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
    Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study.
    Low SK; Zayan AH; Istanbuly O; Nguyen Tran MD; Ebied A; Mohamed Tawfik G; Huy NT
    Leuk Lymphoma; 2019 Dec; 60(14):3406-3416. PubMed ID: 31322026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
    Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
    Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).
    Taneja A; Kumar V; Chandra AB
    Eur J Haematol; 2020 May; 104(5):390-399. PubMed ID: 31769538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for primary diff use large B-cell lymphoma of the brain.
    Zhou Z; Chen J
    Asian J Surg; 2023 Oct; 46(10):4357-4362. PubMed ID: 36535876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.